What amount sold does TISSUE GENESIS INC report in Form D filings?

The latest linked filings report $20.9M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was TISSUE GENESIS INC's most recent SEC filing?

TISSUE GENESIS INC's most recent Form D filing was on 2014-09-03.

How many investors does TISSUE GENESIS INC have?

The most recent Form D filing lists 1 investor(s).

What type of securities does TISSUE GENESIS INC offer?

TISSUE GENESIS INC's SEC Form D filings indicate equity offerings.

TISSUE GENESIS INC

CIK: 0001210070·Biotechnology·HONOLULU, HI·Corporation

Reported Sold

$20,903,714

Total Filings

Identified Offerings

Last Filed

Sep 3, 2014

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 3, 2014Form D — New notice

Reported sold: $500,000 · Target: $6,000,000

Rule 506(b)·1 investor

Jan 4, 2012Form D — New notice

Reported sold: $7,737,709 · Target: $15,300,000

Rule 506·53 investors

Jul 11, 2011Form D — New notice

Reported sold: $5,634,005 · Target: $15,300,000

Rule 506·51 investors

Jan 5, 2011Form D — New notice

Reported sold: $4,461,600 · Target: $15,300,000

Rule 506·40 investors

Jul 2, 2010Form D — New notice

Reported sold: $1,330,400 · Target: $15,300,000

Rule 506·9 investors

Apr 22, 2010Form D — New notice

Reported sold: $120,000 · Target: $9,000,000

Section 4(6)·2 investors

Apr 22, 2010Form D — New notice

Reported sold: $1,120,000 · Target: $9,000,000

Section 4(6)·3 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 7 identified offerings

$20,903,714

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Robert Hiam

Related Person

Appears on 6 filings

Paul Kosnik

Related Person

Appears on 5 filings

Michael Ruley

Related Person

Appears on 5 filings

Anton C. Krucky

Related Person

Appears on 5 filings

Thomas Cannon

Related Person

Appears on 5 filings

Bradley Perkins

Related Person

Appears on 3 filings

William Wiesmann

Related Person

Appears on 3 filings

Jeffery Watanabe

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 3, 2014	New	$6,000,000	$500,000	1
Jan 4, 2012	New	$15,300,000	$7,737,709	53
Jul 11, 2011	New	$15,300,000	$5,634,005	51
Jan 5, 2011	New	$15,300,000	$4,461,600	40
Jul 2, 2010	New	$15,300,000	$1,330,400	9
Apr 22, 2010	New	$9,000,000	$1,120,000	3
Apr 22, 2010	New	$9,000,000	$120,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

28bio, Inc.

Biotechnology

Offering target: $8,524,945

Filed Oct 29, 2026